GlassScriptPhysician profile
Brian L Loc
NPI 1033599691
$6,488.61
in general payments reported to CMS, 2019-2025
29 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,037 · 2020: $1,066 · 2021: $1,305 · 2022: $655 · 2023: $34.25 · 2024: $312 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950 · Travel and Lodging: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.61 |
| Travel and Lodging | $475.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,245.67 | 2019-2020 | |
| Medtronic, INC. | $1,045.37 | 2021-2025 | Micra |
| Abiomed | $571.42 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $545.78 | 2019-2020 | |
| Abbott Laboratories | $414.06 | 2020-2025 | Diamondback Coronary, Optis |
| Boston Scientific Corporation | $412.90 | 2021-2025 | Watchman Access System, Avvigo Guidance System |
| Cardiovascular Systems INC. | $337.35 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.94 | 2019 | |
| Amgen INC. | $246.12 | 2021-2025 | Repatha, Repatha |
| Chiesi USA, INC. | $241.04 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.89 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $137.79 | 2022-2024 | |
| Shockwave Medical, INC | $135.05 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $129.73 | 2021-2025 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $114.67 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $97.42 | 2022 | |
| Astellas Pharma US INC | $92.15 | 2019 | |
| Janssen Scientific Affairs, LLC | $45.04 | 2022 | |
| Teleflex LLC | $44.04 | 2021-2024 | Turnpike |
| Kiniksa Pharmaceuticals International, Plc | $35.38 | 2024 | Arcalyst |
| Getinge USA Sales, LLC | $35.28 | 2021 | |
| Siemens Medical Solutions USA, INC. | $25.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.49 | 2022 | |
| W. L. Gore & Associates, INC. | $22.87 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Asahi Intecc USA, INC. | $20.31 | 2022 | |
| Merck Sharp & Dohme LLC | $20.26 | 2024 | Verquvo |
| Ge Healthcare | $18.69 | 2022 | |
| Pfizer INC. | $14.64 | 2025 | |
| Lantheus Medical Imaging, INC. | $13.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Loc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.